IGC Pharma Announces Equity Research Update by Alliance Global Partners
February 10, 2026
POTOMAC, MARYLAND – February 10, 2026 – IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announced that Alliance Global Partners (“AGP”) has published an updated equity research report covering the Company. The report reiterates a Buy rating and includes a price target of $3.00 per share. All statements, opinions,